title: Authors' response.
authors.forename: Alon
authors.initials: A
authors.lastname: Harris
authors.forename: Brent
authors.initials: B
authors.lastname: Siesky
authors.forename: Ingrida
authors.initials: I
authors.lastname: Januleviciene
authors.forename: Leslie Abrams
authors.initials: LA
authors.lastname: Tobe
authors.forename: Matt
authors.initials: M
authors.lastname: Zore
authors.forename: Annahita
authors.initials: A
authors.lastname: Amireskandari
authors.forename: Noa
authors.initials: N
authors.lastname: Geffen
authors.forename: Barbara
authors.initials: B
authors.lastname: Wirostko
mesh_terms: D016568:Drugs, Generic / Q000627:therapeutic use*; D005128:Eye Diseases / Q000188:drug therapy*; D006801:Humans; D009885:Ophthalmology
chemical_list: D016568:Drugs, Generic
keywords: Drugs; Glaucoma; Treatment Medical